Aslan, Galip Servet IMPRS, Max Planck Institute for Heart and Lung Research, Max Planck Society;
Cremer, S., Pilgram, L., Berkowitsch, A., Stecher, M., Rieg, S., Shumliakivska, M., et al. (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLOS ONE, 16(10): e0258684. doi:10.1371/journal.pone.0258684.